Full-Time

Director SP Supplier Engineering

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Sunnyvale, CA, USA

In Person

Bachelor's

Category
Engineering Management (1)
Required Skills
Agile
Six Sigma
SAP Products
Word/Pages/Docs
Excel/Numbers/Sheets

Get referred to Intuitive Surgical

See people who can refer or advise you

Requirements
  • BA or BS degree or equivalent and 10 or more years related experience in Supplier Management and Development, with significant medical or medical device experience
  • Minimum 5 years of experience leading supplier development or supplier quality engineering teams, or leadership of equivalent areas.
  • Proven ability to lead teams to solve difficult technical and process problems
  • Proven ability to hire highly capable staff, and grow and mentor staff
  • Proven track record of defining and pursuing excellence
  • Deep knowledge of supplier manufacturing processes, to include but not limited to: metal fabrication (machining, turning, molding, stamping, casting), joining and finishing, plastic injection molding and extrusion and wire cabling, MIM, PCA manufacture, disposable medical instruments, robotics components, or sensors/actuators
  • Proven track record of managing to full regulatory compliance in the Supplier areas, both at suppliers and within Supplier Development Function
  • Excellent knowledge of GMPs and experience with a highly complex medical device
  • Excellent knowledge of Lean Manufacturing techniques and best practices, with demonstrated ability to articulate vision to the supplier base, peer group, and direct reports
  • Excellent communication skills (written and verbal); outstanding ability to guide and teach proper technical writing
  • Ability to read and interpret detailed mechanical drawings and communicating technical information
  • Significant computer experience using Windows, Word, Excel and Access and ERP Information Systems, preferably SAP and Agile application software
  • Sense of purpose combined with a strong ability to execute
Responsibilities
  • Develop and maintain a Supplier Engineering and Development program.
  • Build, own and relentlessly pursue a vision for developing suppliers
  • Own and drive to closure supplier variances from symptom through root cause analysis to corrective action, including careful CAPA documentation
  • Select suppliers with appropriate processes to ensure high quality and repeatability
  • Drive supplier process improvements including but not limited to the following programs: 6 Sigma, SPC, and other statistical techniques, supplier certification and rationalization, and Lean Manufacturing Techniques
  • Develop metrics that measure supplier performance and program effectiveness, and manages program of continuous improvement to drive these metrics
  • Reach across the multiple organizations to identify opportunities for supplier development that benefit Intuitive Surgical’s core goals
  • Support Project Management and Commodity Team functions
  • Build department function through training, coaching and recruiting
  • Develop staff skills in project management and statistical process control to grow staff who are capable of addressing difficult problems, apply good judgment, exhibit ownership, and deliver quality work, on time and based on sound science
  • Develop staff skills in auditing suppliers for compliance with supplier agreements and ensuring that agreements are being met
  • Facilitate, influence and work cross-functionally to improve supplier processes with the following: + NPD, NPI and Quality Engineering groups in support of Early Supplier Involvement regarding all new products; reaches into early NPD stages to provide guidance on component selection; assists in design for manufacturing analysis; supports Intuitive design control + Corporate Purchasing group in support of supplier consolidation, cost reduction programs and Commodity Teams + Regulatory and Compliance groups in support of CAPA programs and SCAR resolution + Product Quality Assurance (Systems) and Clinical Engineering groups regarding component and product functional compliance
  • Support the Supplier Quality department in holding responsibility for all aspects of regulatory compliance for suppliers, within the broader scope of Intuitive’s Quality System + Manage Supply Base to full compliance, including all relevant guidance and regulations + Manage Supplier Engineering Function to full compliance
  • Employ proven attention to detail and excellent process to ensure success
  • Understand proper level of documentation detail for tracking of actions and justification of decisions
  • Direct staff to generate daily, weekly, and monthly reports regarding supplier performance; direct supplier corrective actions from VR generation to IQC; support data complaint review data mining, interpretation, and presentation for Quarterly Management reviews
  • Generate key metrics for the team and suppliers and continually drive for timely achievement of those metrics.

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 19% to $2.89 billion, beating estimates on July 16.
  • Penang lease adds 316,000 square feet and 1,200 jobs, supporting Asia-Pacific growth.
  • Management kept 2026 da Vinci growth at 13.5%-15.5% and raised gross-margin guidance.

What critics are saying

  • FDA recall tracker listed multiple 2026 da Vinci Class II recalls, signaling quality-control strain.
  • Medtronic Hugo gained U.S. urology clearance in December 2025, tightening robotic-surgery competition.
  • 2027 extended instrument-use changes risk recurring revenue erosion if hospitals delay upgrades.

What makes Intuitive Surgical unique

  • Da Vinci installed base neared 13,000 systems worldwide, locking in switching costs.
  • Da Vinci 5 launched broadly in the U.S. in 2025, boosting utilization.
  • Ion procedures grew 36% in Q2 2026, extending Intuitive beyond soft-tissue robotics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.

Yahoo Finance
Aug 16th, 2026
Oppenheimer upgrades Intuitive Surgical to 'Outperform' with $500 price target

Oppenheimer upgraded Intuitive Surgical from "Perform" to "Outperform" with a $500 price target, implying a 24.6% upside. The analysts expect the medtech company to maintain its leading position in robotic surgery despite increasing competition. Intuitive reported strong Q2 results, with revenue rising 18.5% year-over-year to $2.89 billion, surpassing analyst expectations. Non-GAAP earnings per share climbed 27.9% to $2.80, beating the $2.50 estimate. The company placed 468 da Vinci surgical systems and 55 Ion endoluminal systems during the quarter. Combined da Vinci and Ion procedures rose approximately 16% globally. Wall Street maintains a "Strong Buy" consensus rating on the stock, with 22 of 31 analysts recommending a strong buy. The consensus price target of $480.93 represents a 19.85% upside.

Yahoo Finance
Aug 12th, 2026
Intuitive Surgical's valuation barely budges despite two years of growth forecasts

Intuitive Surgical trades at $401.23, down 32% from its 52-week high and 15% over twelve months. The stock currently trades at 37.7 times trailing adjusted earnings. Analysts forecast earnings of $12.08 per share by 2027, bringing the multiple down to 33 times — only 13% lower despite two years of growth. Consensus projects 7% annual earnings growth and 9.7% revenue growth, suggesting margin compression ahead. Management raised its 2026 gross profit margin guidance to 68-69%. However, the company plans to extend instrument use limits starting in the first half of 2027 to lower procedure costs and boost adoption. Intuitive has not finalised pricing for this programme, creating uncertainty around 2027 estimates. The company will quantify the impact on its next earnings call.

Yahoo Finance
Aug 8th, 2026
Medtronic and Intuitive Surgical lag market amid sector weakness

Medtronic and Intuitive Surgical, two medical device leaders, have underperformed this year due to sector weakness and company-specific challenges. However, both show potential for recovery. Medtronic's fourth-quarter revenue rose 9.9% to $9.8 billion, though adjusted earnings per share fell 4.3% to $1.55 due to higher costs, including tariffs. The company posted its highest annual revenue growth in a decade, driven partly by its Pulse Field Ablation franchise. Medtronic recently received FDA clearance for its Hugo robotic-assisted surgery system for urologic procedures, positioning it to compete in the underpenetrated robotic surgery market. The company plans to spin off its lower-margin diabetes care division, which should improve margins. With a 3.4% forward dividend yield and 49 consecutive years of payout increases, Medtronic appeals to income-focused investors.